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Abstract
Approximately 15% of infants worldwide are born with low birthweight (<2500 g).
These children are at risk for growth failure. The aim of this umbrella review is to
assess the relationship between infant milk type, fortification and growth in low-
birthweight infants, with particular focus on low- and lower middle–income coun-
tries. We conducted a systematic review in PubMed, CINAHL, Embase and Web of
Science comparing infant milk options and growth, grading the strength of evidence
based on standard umbrella review criteria. Twenty-six systematic reviews qualified
for inclusion. They predominantly focused on infants with very low birthweight
(<1500 g) in high-income countries. We found the strongest evidence for (1) the
addition of energy and protein fortification to human milk (donor or mother's milk)
leading to increased weight gain (mean difference [MD] 1.81 g/kg/day; 95% confi-
dence interval [CI] 1.23, 2.40), linear growth (MD 0.18 cm/week; 95% CI 0.10, 0.26)
and head growth (MD 0.08 cm/week; 95% CI 0.04, 0.12) and (2) formula compared
with donor human milk leading to increased weight gain (MD 2.51 g/kg/day; 95% CI
1.93, 3.08), linear growth (MD 1.21 mm/week; 95% CI 0.77, 1.65) and head growth
(MD 0.85 mm/week; 95% CI 0.47, 1.23). We also found evidence of improved
growth when protein is added to both human milk and formula. Fat supplementation
did not seem to affect growth. More research is needed for infants with birthweight
1500–2500 g in low- and lower middle–income countries.
K E YWORD S
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1 | INTRODUCTION
Approximately 15% of infants are born with low birthweight
(LBW) (<2500 g) (Blencowe et al., 2019). Compared with normal-
birthweight infants, LBW infants have increased risk for morbidity and
mortality. Small size at birth contributes to 80% of neonatal deaths
(Lawn et al., 2014), and LBW infants frequently experience poor post-
natal growth (Cooke et al., 2004). Early growth failure has been
associated with poor outcomes, including negative effects on
neurodevelopment (Ehrenkranz et al., 2006). Optimal nutrition forPROSPERO registration number: CRD42019121370.
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LBW infants, both during their initial hospitalization after birth and
after their discharge to home, is important for survival, growth and
normal development.
In 2011, the World Health Organization (WHO) published a broad
review of LBW nutrition, Guidelines on Optimal Feeding for Low-
Birthweight Infants in Low- and Middle-Income Countries. The guidelines
recommended mother's unfortified milk as the initial option for feed-
ing LBW infants, with donor human milk being the next best choice if
mother's milk is not available. Fortification of human milk was rec-
ommended only in the case of inadequate weight gain. Notably, most
of the studies included in this WHO review were judged to be of poor
quality, such that 13 of the 18 guidelines (72%) are based on ‘weak’
or ‘weak situational’ evidence.
A number of systematic reviews of the feeding of LBW infants
have been published since the establishment of the WHO guidelines.
We chose to conduct an umbrella review, an overview of systematic
reviews, to coalesce the data on a large number of feeding interven-
tions. Umbrella reviews are used to synthesize evidence on a broad
topic and facilitate decision making (Biondi-Zoccai, 2016). The objec-
tive of this umbrella review is to summarize the available review litera-
ture on the relationship between milk options for LBW infants,
including human milk, infant formula and infant milk fortifiers, and
growth up to 6 months post-term. We hope that this evidence
synthesis may provide guidance for the formation of feeding recom-
mendations, while acknowledging that many other factors, such as
morbidities including necrotizing enterocolitis, cost and feasibility, are
also important considerations to guide feeding choices.
The prevalence of LBW is disproportionately high in low- and
middle-income countries (LMICs). An estimated 91% of LBW infants
are born in LMICs (Blencowe et al., 2019). Given the size and
vulnerability of this population, we were particularly interested in
principles for feeding LBW infants that are tailored to resource-
limited environments. In undertaking this umbrella review, we antici-
pated that the bulk of research on the feeding of LBW infants has
been conducted in high-income settings. Because we were inter-
ested in conducting a comprehensive search, we chose not to
restrict our inquiry to LMICs but to pay particular attention to the
results stemming from this group. Because the preponderance of
LBW infants surviving from LMICs fall into the 1500–2500 g weight
band, we have a special interest in infants with these birthweights.
As much as possible, we wanted to synthesize the available evidence
to formulate recommendations for feeding LBW infants in LMICs,
while acknowledging the limitations in extrapolating principles
between populations.
2 | METHODS
We followed the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) guidelines while conducting this review
(see Data S1). We registered the protocol for this review with PROS-
PERO prior to review initiation and submitted updates for protocol
modifications. The full protocol is available in the Data S1.
2.1 | Search strategy
We conducted a search of Medline, CINAHL, Embase and Web of
Science databases. The initial query was done in Medline, CINAHL
and Embase in December 2018 with the addition of studies from the
Web of Science in March 2019. The search was updated in January
2020. Search terms included probes for ‘low birthweight’, ‘prema-
ture’, ‘small for gestational age’, ‘breast milk’, ‘infant formula’, and
‘systematic review’, in addition to a number of related terms (see
Data S1). We limited our selection to articles published in English and
only included systematic reviews or meta-analyses. We had no limita-
tions on publication dates. If multiple versions of a systematic review
were available, we only included the most recently updated version.
We only included reviews for which full-text articles were available
and did not include studies from the grey literature.
2.2 | Population, intervention and outcomes
Our population of interest was LBW infants. As such, we limited our
umbrella review population to reviews primarily targeted to preterm
infants or those with birthweight <2500 g. We calculated a pooled
weighted average birthweight among the primary studies included in
each review both to see if the population met the inclusion criteria
(<2500 g) and to better understand the profile of the population rep-
resented by the review.
We considered interventions relating to infant milk options,
including types of milk such as formula or human milk and milk
fortification with macronutrients including added fat, carbohydrate or
protein components. Reviews only addressing vitamin or mineral forti-
fication were excluded. We included both inpatient and outpatient
Key messages
• Energy (fat or carbohydrate) and protein fortification of
human milk is associated with increased growth in low-
birthweight infants during birth hospitalization, although
not associated with increased growth between discharge
and 6 months.
• Formula compared with donor human milk is associated
with increased growth in low-birthweight infants.
• Most low birthweight feeding studies have focused on
infants with a birthweight <1500 g; only a few focus on
infants with birthweight 1500 to <2500 g, a group with a
unique nutritional profile.
• Only a small percentage of the studies of nutritional
interventions for low-birthweight infants have been con-
ducted in low- and lower middle–income countries.
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interventions. Comparison groups varied by review, but all included
unfortified mother's own milk and/or other infant milk and fortifica-
tion options.
Our outcome of interest was growth assessed through measure-
ment of weight, length, head circumference, body composition,
skinfold thickness or fat-free mass. Reviews that did not report
anthropometrics were excluded. We included growth outcomes from
birth up to 6 months post-term.
2.3 | Study selection and data extraction
Two reviewers (K. N. and M. M. D.) independently screened eligible
articles first by title and abstract, then full text. We determined inclu-
sion based on population, intervention and outcome criteria discussed
previously. Any screening conflicts were resolved through discussion
between the two reviewers and adjudication by a third reviewer
(K. E. A. S.). In accordance with PRISMA guidelines, two reviewers
(K. N. and M. M. D.) independently completed data extraction for 50%
of the included studies and independently achieved >80% agreement
(K.N. and M. M. D.), with a single reviewer extracting data from the
remainder of the studies (K. N.). See the Data S1 for a complete list of
extracted information.
2.4 | Data analysis
We evaluated the risk of bias of selected reviews using the ‘A Mea-
surement Tool to Assess Systematic Reviews (AMSTAR 2)’ checklist, a
quality assessment tool specifically designed for systematic reviews
(Shea et al., 2017). The strength of evidence from every unique meta-
analysis was graded on the basis of conventions established in other
umbrella reviews (Belbasis et al., 2015; Bellou et al., 2017; Fusar-Poli
& Radua, 2018). We extracted all data used to grade the evidence
from the reviews. We did not calculate a pooled effect size between
reviews. The evidence was classified as follows:
• Convincing: fixed- or random-effects P-value <0.00001, population
size >500, 95% confidence interval excludes null, heterogeneity I2
value <50%.
• Highly suggestive: does not meet criteria for convincing and fixed-
or random-effects P-value <0.00001, population size >500, largest
study excludes null.
• Suggestive: does not meet criteria for convincing and fixed- or
random-effects P-value <0.001, population size >500.
• Weak: does not meet criteria for convincing and fixed- or random-
effects P-value <0.05
• Not significant: fixed- or random-effects P-value >0.05
3 | RESULTS
We screened the titles and abstracts of 1278 references. Sixty full-
text articles were reviewed, and 26 reviews met eligibility criteria
for data extraction (Figure 1). A list of full text articles that were
not included as well as reasons for elimination is shown in the Data
S1. These 26 review articles included 150 unique studies. Some of
these studies were included in more than one systematic review. A
list of individual studies included in multiple reviews is shown in the
Data S1.
F IGURE 1 Flow chart of selection of eligible
reviews
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3.1 | Characteristics of included reviews
The included reviews address a number of feeding options for LBW
infants (Table 1). Twenty-one of the 26 reviews had a pooled
weighted average birthweight of 900–1499 g. Four reviews had a
pooled weighted average birthweight between 1500 and <2500 g.
Twenty-three reviews limited their population to studies of premature
infants. One review specifically addressed infants who were term but
small for gestational age (SGA) (Santiago et al., 2019). Twenty reviews
reported the country or region that was the setting of the primary
studies. Of these, 98% (147/150) of primary studies were conducted
in upper middle– or high-income countries or predominantly high-
income regions. Two per cent of primary studies (3/150) occurred in
India, a lower middle–income country. No studies occurred in low-
income countries. See the Data S1 for additional study details. Nine-
teen reviews conducted formal meta-analyses, whereas seven reviews
presented outcomes as a narrative summary of included studies. Some
reviews included population-based or non-randomized studies (Data
S1). Authors were limited in the conclusions that could be drawn from
these studies. Studies without a control population were not included
in meta-analyses and thus did not impact the effect size.
3.2 | Quality assessment of included reviews
None of the included reviews met AMSTAR 2 criteria to be
considered high quality. Seventeen of the 26 systematic reviews were
of moderate quality. Seven reviews were considered low quality, and
two were considered critically low quality. See Figure 2 and Table 1
for AMSTAR 2 results.
3.3 | Outcomes by intervention
Figure 2 summarizes key outcomes including the quality of evidence.
The effect size and 95% confidence intervals of key meta-analyses are
depicted as forest plots in Figure 3. See Data S1 for detailed growth
outcomes of individual reviews.
3.3.1 | Donor human milk compared with formula
Three reviews comparing donor human milk with formula found
consistently greater growth in the formula group (Boyd et al., 2007;
Quigley et al., 2018 ; Yu et al., 2019). In a systematic review by Quigley
et al., the formula group demonstrated greater weight gain during birth
hospitalization in the neonatal unit compared with the donor human
milk group (mean difference [MD] 2.51 g/kg/day; 95% confidence inter-
val [CI] 1.93, 3.08), linear growth (MD 1.21 mm/week; 95% CI 0.77,
1.65), and head growth (MD 0.85 mm/week; 95% CI 0.47, 1.23)
(Quigley et al., 2018; Yu et al., 2019). In a subgroup analysis comparing
formula versus donor human milk as a supplement to mother's own milk,
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95% CI 1.23, 3.21), but linear growth (MD 0.67 mm/week; 95% CI
−0.04, 1.38) and head growth (MD 0.24 mm/week; 95% CI −0.32, 0.80)
were no longer significantly different for formula compared with donor
human milk (Quigley et al., 2018). A review by Yu et al. also showed
improved growth in the formula versus donor human milk group for
weight gain (MD 6.58 g/day; 95% CI 1.98, 11.19) and linear growth
(MD 0.30 cm/week; 95% CI 0.20, 0.41). In a subgroup analysis of
growth by birthweight category, both the group of infants with
birthweight <1000 g and infants with birthweight 1000–1500 g
demonstrated significantly greater weight gain in the formula group
(birthweight <1000 g: MD 2.80 g/day; 95% CI 1.20, 4.39; birthweight
1000–1500 g: MD 10.42 g/day; 95% CI 8.53, 12.30) (Yu et al., 2019).
Boyd and colleagues did not perform a meta-analysis but presented a
narrative summary of studies comparing donor human milk and formula.
Most studies in this review found greater weight, length, head
circumference and skinfold thickness gains in the formula group when
given as either an exclusive diet or as a supplement to mother's own
milk (Boyd et al., 2007).
3.3.2 | Exclusive breastfeeding
A single review compared exclusive breastfeeding with a number of
other infant feeding options for full-term infants who were small for
F IGURE 2 Outcomes and quality of
evidence for key meta-analyses included in
this umbrella review are grouped by type of
intervention. The direction and significance of
the weighted mean difference are indicated
by the colour of the circle. The quality of the
evidence is indicated by the size of the circle.
See key for further detail. Abbreviations: CI,
confidence interval; Circum, circumference;
DHM, donor human milk; LA, linoleic acid; LC
PUFA, long-chain polyunsaturated fatty acids;
MCT, medium-chain triglycerides; MD, mean
difference
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gestational age (Santiago et al., 2019). Santiago et al. did not conduct
a meta-analysis, but the individual studies in this review demonstrated
heterogeneous findings with regard to weight gain and linear growth
in infants fed human milk, fortified human milk, preterm formula and
term formula (Santiago et al., 2019).
3.3.3 | Hydrolyzed infant milk
Two reviews investigated the impact of hydrolyzed feeds on infant
growth. Hydrolyzed protein formula, in which the milk proteins have
been chemically or enzymatically digested to oligopeptides, was
associated with significantly lower weight gain (MD −3.02 g/kg/day;
95% CI −4.55, −1.38) compared with standard formula, although
linear growth (MD −0.04 mm/week; 95% CI −1.24, 1.15) and head
growth (MD 0.27 mm/week; 95% CI −0.39, 0.94) were not different
between the groups (Ng et al., 2019). Infant formula and human
milk treated with lactase compared with standard formula and
human milk demonstrated no significant difference in weight gain
(day 14: MD 2.7 g/day; 95% CI −1.47, 6.87; study exit: MD
2.2 g/day; 95% CI −0.98, 5.3), linear growth (day 14 or study exit:
MD 0.30 cm/week; 95% CI −0.13, 0.73) or head circumference
(day 14 or study exit: MD 0.10 cm/week; 95% CI −0.18, 0.38)
(Tan-Dy & Ohlsson, 2013).
3.3.4 | Energy and protein fortification of infant
milk
Several reviews investigated the impact of energy (fat or carbohy-
drate) and protein fortification of either human milk or formula and
found significantly higher growth during birth hospitalization. Brown
et al. examined energy and protein fortification of human milk
during the birth hospitalization of preterm infants. They found
greater weight gain (MD 1.81 g/kg/day; 95% CI 1.23, 2.40), linear
growth (MD 0.18 cm/week; 95% CI 0.10, 0.26) and head growth
(MD 0.08 cm/week; 95% CI 0.04, 0.12) in the fortified group
(Brown et al., 2016; Walsh et al., 2019). Walsh et al. examined the
effect of energy/protein fortification of formula during birth
hospitalization on preterm infant growth. They found greater
weight gain (MD 2.43 g/kg/day; 95% CI 1.60, 3.26) and head
growth (MD 1.04 mm/week; 95% CI 0.18, 1.89) but no difference
in linear growth (MD 0.22 mm/week; 95% CI −0.70, 1.13) in the
fortified group.
F IGURE 3 Effect size and 95% confidence
intervals of key meta-analyses demonstrating the
mean difference in weight gain, linear growth and
head growth between feeding groups.
Abbreviations: MD, mean difference; CI,
confidence interval; g/kg/d, grams/kilogram/day;
cm/wk, centimetres/week; DHM, donor human
milk; HM, human milk; MCT, medium chain
triglyceride
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However, energy and protein fortification seemed to have little
impact on preterm infants after they left the hospital. Three reviews
specifically investigated the impact of energy and protein fortification
on postdischarge growth (Teller et al., 2016; Young et al., 2013;
Young et al., 2016). Infants fed either postdischarge formula
(about 72–74 kcal/100 ml) or preterm formula (about 80 kcal/100 ml)
compared with standard formula (about 66–68 kcal/100 ml) after dis-
charge from the hospital did not have greater 6-month weight (post-
discharge formula: MD 35.54 g; 95% CI −113.71, 184.78; preterm
formula: MD 74.60 g; 95% CI −164.73, 313.92), length (postdischarge
formula: MD 2.12 mm; 95% CI −2.16, 6.41; preterm formula: MD
1.83 mm; 95% CI −6.25, 9.92), or head circumference (postdischarge
formula: MD 2.28 mm; 95% CI −0.28, 4.83) except for higher head
circumference in the preterm formula group (MD 5.82 mm; 95% CI
1.32, 10.32) (Young et al., 2016). Similarly, a qualitative systematic
review found mixed results of energy and protein-fortified formula on
growth (Teller et al., 2016). Meta-analysis of energy and protein-
fortified human milk also found no impact on postdischarge weight
(MD 138.26 g; 95% CI −89.87, 366.40), length (MD 0.06 cm; 95% CI
−0.14, 1.33), or head circumference at 3 to 4 months post-term
(MD 0.22 cm; 95% CI −0.15, 0.58) (Young et al., 2013).
3.3.5 | Carbohydrate only fortification
One review investigated carbohydrate fortification of human milk
with a nonhuman short-chain galacto-oligosaccharide/long-chain
fructo-oligosaccharide supplement (Amissah et al., 2018a). The weight
in the intervention group was higher at 30 days compared with infants
fed nonfortified human milk (MD 160.4 g; 95% CI 12.4, 308.4). Other
growth metrics were not reported.
3.3.6 | Fat only fortification
Several reviews analysing fat fortification of both human milk and for-
mula found that it makes no difference in growth. Five reviews specifi-
cally addressed the effect of long-chain polyunsaturated fatty acids
(LC PUFA) (Gibson et al., 2001; Moon et al., 2016; Newberry
et al., 2016; Rodríguez et al., 2012; Udell et al., 2005). Three meta-
analyses of formula fortified with LC PUFA showed no statistically sig-
nificant effect on weight, length or head circumference within the first
6 months of life (Moon et al., 2016; Newberry et al., 2016; Udell
et al., 2005). Two systematic reviews described mixed results in a quali-
tative assessment (Gibson et al., 2001; Rodríguez et al., 2012). A meta-
analysis of general fat fortification found no impact on growth, though
only one small study was reported (weight gain: MD 0.60 g/kg/day;
95% CI −2.4, 3.6; linear growth: MD 0.1 cm/week; 95% CI −0.08, 0.3;
head growth: MD 0.2 cm/week; 95% CI −0.07, 0.40) (Amissah
et al., 2018b). A review of high versus low medium-chain triglyceride
fortification found no difference in weight gain (MD −0.35 g/kg/day;
95% CI −1.44, 0.74), linear growth (MD 0.14 cm/week; 95% CI −0.04,
0.31), head growth (MD −0.03 cm/week; 95% CI −0.15, 0.08),
or increase in skinfold thickness (MD −0.15 mm/week; 95% CI −0.41,
0.11) (Nehra et al., 2002).
3.3.7 | Protein and amino acid fortification
Five reviews examined the impact of protein fortification on growth;
most reported increased growth associated with protein supplementa-
tion (Amissah et al., 2018c; Fenton et al., 2014; Liu et al., 2015;
Pimpin et al., 2019; Tonkin et al., 2014). A review of protein-fortified
versus unfortified human milk reported increased growth in the
intervention group (weight gain: MD 3.82 g/kg/day; 95% CI 2.94,
4.70; linear growth: MD 0.12 cm/week; 95% CI 0.07, 0.17; head
growth: MD 0.06 cm/week; 95% CI 0.01, 0.12) (Amissah
et al., 2018c). Similarly, a review of high- versus low-protein fortifica-
tion of human milk found increased weight gain, linear growth and
head growth in the higher-protein group (Liu et al., 2015). Increased
weight gain (MD 2.36 g/kg/day; 95% CI 1.3, 3.4) and head growth
(MD 0.37 cm/week; 95% CI 0.16, 0.58) were also seen in a compari-
son of high- versus low-protein formula (Fenton et al., 2014). One
review of protein-fortified infant milk, including both human milk and
formula, found no difference in weight (MD 0.19 kg; 95% CI −0.03,
0.42) or length (MD 0.06 cm; 95% CI −0.22, 0.34) but a significant
decrease in weight-for-age (MD −0.81; 95% CI −1.16, −0.46), length-
for-age (MD −1.31; 95% CI −1.60, −1.01) and weight-for-length
(MD −1.57; 95% CI −2.02, −1.12) Z scores of the protein-fortified
groups compared with unfortified or lower-protein human milk
(Pimpin et al., 2019).
Two reviews examining the effect of individual amino acid fortifi-
cation found no difference in growth was observed (Cao et al., 2018;
Moe-Byrne et al., 2016). Taurine fortification in formula was associ-
ated with a decrease in linear growth (MD −0.18 cm/week; 95% CI
−0.27, −0.09) but no effect on weight gain (MD 0.28 g/kg/day; 95%
CI −0.47, 1.03) or head growth (MD 0.05 cm/week; 95% CI −0.06,
0.16) (Cao et al., 2018). For Moe-Byrne et al., no meta-analysis was
conducted, but glutamine fortification was not found to affect weight
gain in two of three primary studies described in the systematic
review. One primary study was reported to show a positive associa-
tion with weight gain, linear growth and head growth, although the
review did not calculate an effect size (Moe-Byrne et al., 2016).
3.4 | Strength of evidence for individual meta-
analyses
Nineteen systematic reviews presented the data for a combined total
of 100 meta-analyses. We graded the quality of evidence of the individ-
ual meta-analyses on the basis of established criteria commonly used in
umbrella reviews as convincing, highly suggestive, suggestive, weak or
nonsignificant (Belbasis et al., 2015; Bellou et al., 2017; Fusar-Poli &
Radua, 2018). See Data S1 for a complete list of meta-analyses and
associated strength of evidence components. No individual meta-
analysis met criteria of convincing or highly suggestive evidence. Seven
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associations were supported by suggestive evidence. These included
greater weight gain, linear growth and head growth associated with
(1) energy and protein-fortified human milk compared with unfortified
human milk and (2) formula (term or preterm) compared with donor
human milk (fortified or unfortified), as well as greater weight gain asso-
ciated with preterm formula compared with fortified donor human milk.
Fifty meta-analyses met criteria for weak evidence. Thirty-nine meta-
analyses were not significant. Four meta-analyses were not adequately
assessed because of the absence of data.
4 | DISCUSSION
4.1 | Summary of main results
This umbrella review found 26 reviews composed of 150 unique
primary studies evaluating the effect of infant milk options on the
growth of LBW infants up to 6 months post-term. We found evidence
that energy and protein fortification of human milk is associated
with increased weight gain, linear growth and head circumference
compared with unfortified human milk (quality: suggestive) (Brown
et al., 2016). We also found evidence that formula is associated with
increased weight gain, linear growth and head growth compared with
donor human milk (quality: suggestive) (Quigley et al., 2019).
These specific findings stand in contrast to the WHO's Guidelines
on Optimal Feeding for Low-Birthweight Infants in Low- and Middle-
Income Countries (2011), which recommend donor human milk over
formula and fortification only in the case of growth failure. The WHO
recommendations are strongly influenced by the protective effects of
human milk against necrotizing enterocolitis. We acknowledge that
many factors beyond a simple calculation of growth are important to
consider in the formation of feeding recommendations, but our find-
ings beg the question of what is the most appropriate feeding strategy
for this population, particularly for infants with birthweight 1500 to
<2500 g who are at lower risk for necrotizing enterocolitis than
infants with birthweight <1500 g.
Multiple systematic reviews supported the use of higher protein
content in both human milk and formula to increase growth, although
the sample size was too small for this evidence to be considered
‘suggestive’, as defined by umbrella review criteria. Several
interventions did not result in increased growth. These include infant
milk with added fat, carbohydrate, LC-PUFA, glutamine or taurine.
Hydrolyzation also seemed to make no difference in growth. These
interventions generally occurred during the birth hospitalization.
Several reviews investigated the question of postdischarge
fortification of human milk and formula. This was generally not
associated with increased anthropometric parameters at 3 to 4 months
or 6 months post-term (Young et al., 2013, 2016). This finding raises
questions about the continued use of fortification after discharge, a
common practice following the initial hospitalization of LBW infants.
The use of energy and protein-fortified formula may be less practical
for many families because of limited access and increased cost
of fortified formula compared with standard formula. Energy and
protein-fortified human milk requires the steps of expressing the milk,
mixing it with milk fortifier, and bottle feeding an infant, a process that
can be burdensome compared with direct breastfeeding.
It is important to acknowledge that we considered greater growth
to be desirable in this population given the high risk for poor growth
early in life and associated morbidities. There is increasing evidence
that children who were born with LBW are at increased risk for
metabolic syndrome later in life, particularly those who were SGA.
The paradigm of ‘growth is good’ may not be appropriate in an older
cohort. We attempted to include more nuanced measures of growth
such as skinfold thickness or fat-free mass but found little data in the
review literature.
4.2 | Quality of the evidence
We evaluated the quality of evidence for individual meta-analyses
included in this review based on extracted data. No meta-analysis met
the criteria for convincing evidence. The comparison of formula (term
or preterm) with donor human milk (unfortified or fortified) by Quigley
et al. (2019) would have been considered convincing if the fixed-
effects P-value were <0.00001 instead of the actual value of exactly
0.00001, which downgraded the quality to ‘weak’. Seven meta-
analyses were considered suggestive. All other meta-analyses for
which sufficient information was available were considered to have
weak quality of evidence or be nonsignificant. The quality of many
meta-analyses was downgraded because of the size of the review
population. Many studies were small, possibly a reflection of the limi-
tations inherent in conducting studies on LBW infants.
4.3 | Completeness and applicability of the
evidence
In addition to limitations due to the quality of evidence, the gene-
ralizability of the included reviews may be limited because of the pop-
ulation represented within the primary studies. Most reviews were
primarily composed of studies of very low birthweight (VLBW)
(birthweight <1500 g) preterm infants in high-income countries.
Although we sought to include recommendations for all LBW
infants, the study populations in the included reviews were
concentrated within the VLBW weight band. Eighty-one per cent of
reviews had an average population birthweight between 1000 and
1500 g, whereas only 15% had an average birthweight falling between
1500 and <2500 g (Cao et al., 2018; Fenton et al., 2014; Gibson
et al., 2001; Santiago et al., 2019). Most of these were deemed to be
low quality on the basis of the AMSTAR 2 rating (Cao et al., 2018;
Gibson et al., 2001; Santiago et al., 2019). This is significant because
the growth patterns of VLBW infants cannot necessarily be extrapo-
lated to infants within the higher birthweight population. Based on
our findings, the unique population of infants with birthweight
between 1500 and <2500 g is underrepresented in the current review
literature. These infants constitute the majority of LBW infants, but
10 of 13 NORTH ET AL.
the current WHO recommendations are based on literature with a
population that is not truly representative of this contingent of the
LBW population.
SGA full-term infants were another LBW group that was under-
represented among these reviews. SGA infants have unique growth
patterns and nutritional requirements (Tudehope et al., 2013). Only
one low-quality review specifically focused on full-term infants who
were SGA (Santiago et al., 2019). Nutritional recommendations for a
VLBW preterm population cannot necessarily be extrapolated to the
SGA full-term infant. This is particularly important for an LMIC setting,
in which the majority of LBW infants will be SGA but term (Lee
et al., 2013).
We found that the majority of research on LBW feeding was con-
ducted in high- or upper middle–income countries, which does not
align with the greatest global prevalence of this population. Among
the 121 studies with a location that was identified in the reviews,
118 were conducted in high- or upper middle–income countries or
regions, and three studies were conducted in India, a lower middle–
income country. No studies were identified with a setting in a low-
income country or from sub-Saharan Africa. The majority of LBW
infants are born in low- or lower middle–income countries, but these
children are not well represented in the current body of research
(Blencowe et al., 2019). The data regarding growth of infants in high-
income settings cannot necessarily be extrapolated to a low-income
population. For instance, studies of formula fortification in term
children have demonstrated larger effects on weight and height in
populations with a lower baseline nutritional status, suggesting that
an at-risk group may experience different growth patterns (Pimpin
et al., 2019). More research is warranted on the optimal feeding of
LBW infants within the context of low- and lower middle–income
countries.
4.4 | Limitations
The umbrella review methodology facilitates the evaluation of a broad
research question in a manner difficult to achieve in an individual sys-
tematic review. We chose to conduct this type of review given the
breadth of literature regarding nutrition of LBW infants. The scope
that can be achieved is sweeping in nature; however, the overview
methodology has a number of inherent limitations. Primary studies
related to the research question but not included in other systematic
reviews may be missed, potentially excluding valuable information.
Umbrella reviews are necessarily limited to the most recent literature
preceding the search date of the individual systematic reviews. The
majority of reviews in our study were published in the past 5 years,
but four reviews were >10 years old. We used a strength of evidence
classification system that has been well described in the umbrella
review literature, but which relies heavily upon P-values. The P-value
is a potentially misleading tool for determining the quality of a study,
as it does not account for risk of bias or the degree to which a signifi-
cant result may be clinically meaningful. We have included the
AMSTAR 2 results and the forest plans with effect size and 95%
confidence intervals to provide a more complete picture of the quality
and strength of the evidence for the individual systematic reviews and
meta-analyses included in this umbrella review.
Given the broad scope of interventions that we considered in this
review, we limited our outcome of interest to infant growth. Necrotiz-
ing enterocolitis, neurodevelopment, kidney function and a number of
other outcomes in preterm infants have all been correlated with the
choice of infant milk and milk components. Choosing to focus on a
single outcome, albeit an important one, provides an incomplete
picture of the effect of nutrition on the heterogeneous components
of health and well-being.
We were interested in all metrics of growth but found the major-
ity of growth outcomes were reported as weight gain, linear growth
and head growth. Important measures of body composition, such as
fat-free body mass or skinfold thickness, received very little attention
in the review literature.
5 | CONCLUSION
Through this umbrella review, we were able to conduct a high-level
survey of the landscape of evidence on various sources of nutrition
for LBW infants and their association with growth that led us to a
number of conclusions.
(1) Energy and protein fortification of human milk is associated with
increased weight gain, linear growth and head growth (quality of
evidence: suggestive).
(2) Formula compared with donor human milk is associated with
increased weight gain, linear growth and head growth (quality of
evidence: suggestive).
(3) Studies of the ideal nutritional interventions for LBW infants in
low- and lower middle–income countries are vastly underrepre-
sented in the literature.
(4) Reviews of infant milk interventions are focused primarily on
the <1500 g birthweight population, with few studies focused
primarily on infants in the 1500 to <2500 g weight band, a
group that may have a unique nutritional and growth profile.
Based on the gaps we have identified, we recommend
additional research focused on the nutritional needs of infants with a
birthweight 1500 to <2500 g and infants born in LMICs because both
of these subgroups represent vulnerable populations who are under-
represented in the available review literature. We included all growth
metrics in our search but found very few outcomes in the reviews
addressing body composition or assessment of lean versus fat mass,
important areas of focus for future research.
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